ID   HOIL1_MOUSE             Reviewed;         508 AA.
AC   Q9WUB0; A2ANR4; Q3TM86; Q8C2I0;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   15-JAN-2008, sequence version 2.
DT   07-APR-2021, entry version 171.
DE   RecName: Full=RanBP-type and C3HC4-type zinc finger-containing protein 1;
DE            EC=2.3.2.31 {ECO:0000250|UniProtKB:Q9BYM8};
DE   AltName: Full=Heme-oxidized IRP2 ubiquitin ligase 1 homolog;
DE            Short=HOIL-1;
DE   AltName: Full=RING-type E3 ubiquitin transferase HOIL-1 {ECO:0000305};
DE   AltName: Full=UbcM4-interacting protein 28;
DE   AltName: Full=Ubiquitin-conjugating enzyme 7-interacting protein 3;
GN   Name=Rbck1; Synonyms=Rbck, Ubce7ip3, Uip28;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=NOD; TISSUE=Lung, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=FVB/N; TISSUE=Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-508.
RC   STRAIN=BALB/cJ; TISSUE=Liver;
RX   PubMed=10431818; DOI=10.1016/s0014-5793(99)00823-6;
RA   Martinez-Noel G., Niedenthal R., Tamura T., Harbers K.;
RT   "A family of structurally related RING finger proteins interacts
RT   specifically with the ubiquitin-conjugating enzyme UbcM4.";
RL   FEBS Lett. 454:257-261(1999).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-328, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Mast cell;
RX   PubMed=17947660; DOI=10.4049/jimmunol.179.9.5864;
RA   Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y.,
RA   Kawakami T., Salomon A.R.;
RT   "Quantitative time-resolved phosphoproteomic analysis of mast cell
RT   signaling.";
RL   J. Immunol. 179:5864-5876(2007).
RN   [6]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=19136968; DOI=10.1038/ncb1821;
RA   Tokunaga F., Sakata S., Saeki Y., Satomi Y., Kirisako T., Kamei K.,
RA   Nakagawa T., Kato M., Murata S., Yamaoka S., Yamamoto M., Akira S.,
RA   Takao T., Tanaka K., Iwai K.;
RT   "Involvement of linear polyubiquitylation of NEMO in NF-kappaB
RT   activation.";
RL   Nat. Cell Biol. 11:123-132(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, and Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   INTERACTION WITH EYA1.
RX   PubMed=20956555; DOI=10.1128/mcb.01645-09;
RA   Landgraf K., Bollig F., Trowe M.O., Besenbeck B., Ebert C., Kruspe D.,
RA   Kispert A., Hanel F., Englert C.;
RT   "Sipl1 and Rbck1 are novel Eya1-binding proteins with a role in
RT   craniofacial development.";
RL   Mol. Cell. Biol. 30:5764-5775(2010).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 192-250 IN COMPLEX WITH LINEAR
RP   DIUBIQUITIN.
RX   PubMed=22139374; DOI=10.1073/pnas.1109088108;
RA   Sato Y., Fujita H., Yoshikawa A., Yamashita M., Yamagata A., Kaiser S.E.,
RA   Iwai K., Fukai S.;
RT   "Specific recognition of linear ubiquitin chains by the Npl4 zinc finger
RT   (NZF) domain of the HOIL-1L subunit of the linear ubiquitin chain assembly
RT   complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:20520-20525(2011).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase, which accepts ubiquitin from
CC       specific E2 ubiquitin-conjugating enzymes, such as UBE2L3/UBCM4, and
CC       then transfers it to substrates. Functions as an E3 ligase for oxidized
CC       IREB2 and both heme and oxygen are necessary for IREB2 ubiquitination.
CC       Promotes ubiquitination of TAB2 and IRF3 and their degradation by the
CC       proteasome. Component of the LUBAC complex which conjugates linear
CC       ('Met-1'-linked) polyubiquitin chains to substrates and plays a key
CC       role in NF-kappa-B activation and regulation of inflammation. LUBAC
CC       conjugates linear polyubiquitin to IKBKG and RIPK1 and is involved in
CC       activation of the canonical NF-kappa-B and the JNK signaling pathways.
CC       Linear ubiquitination mediated by the LUBAC complex interferes with
CC       TNF-induced cell death and thereby prevents inflammation. LUBAC is
CC       recruited to the TNF-R1 signaling complex (TNF-RSC) following
CC       polyubiquitination of TNF-RSC components by BIRC2 and/or BIRC3 and to
CC       conjugate linear polyubiquitin to IKBKG and possibly other components
CC       contributing to the stability of the complex. Together with OTULIN, the
CC       LUBAC complex regulates the canonical Wnt signaling during
CC       angiogenesis. Binds polyubiquitin of different linkage types (By
CC       similarity). {ECO:0000250|UniProtKB:Q9BYM8}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[E2 ubiquitin-conjugating enzyme]-S-ubiquitinyl-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + [acceptor protein]-N(6)-ubiquitinyl-L-lysine.;
CC         EC=2.3.2.31; Evidence={ECO:0000250|UniProtKB:Q9BYM8};
CC   -!- SUBUNIT: Component of the LUBAC complex (linear ubiquitin chain
CC       assembly complex) which consists of SHARPIN, RBCK1 and RNF31 (By
CC       similarity). LUBAC has a MW of approximately 600 kDa suggesting a
CC       heteromultimeric assembly of its subunits (By similarity). Interacts
CC       with beta-I-type (PRKCB1) and zeta-type protein kinase C (PRKCZ) and
CC       with UBE2L3 (By similarity). Interacts with IREB2 only in iron-rich
CC       conditions (By similarity). Associates with the TNF-R1 signaling
CC       complex (TNF-RSC) in a stimulation-dependent manner (By similarity).
CC       Interacts with EYA1, TAB2, TAB3, MAP3K7 TRAF6 and RIPK1
CC       (PubMed:20956555). Interacts with IRF3 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9BYM8, ECO:0000269|PubMed:20956555}.
CC   -!- INTERACTION:
CC       Q9WUB0; P97767: Eya1; NbExp=2; IntAct=EBI-6141072, EBI-1368503;
CC       Q9WUB0; Q924T7: Rnf31; NbExp=10; IntAct=EBI-6141072, EBI-647680;
CC   -!- DOMAIN: The RanBP2-type zinc finger, also called Npl4 zinc finger
CC       (NZF), mediates binding to 'Met-1'-linked polyubiquitins.
CC       {ECO:0000269|PubMed:22139374}.
CC   -!- DOMAIN: The UBL domain mediates association with RNF31 via interaction
CC       with its UBA domain. {ECO:0000250|UniProtKB:Q9BYM8}.
CC   -!- PTM: Auto-ubiquitinated. Auto-ubiquitination leads to degradation by
CC       the proteasome (By similarity). {ECO:0000250|UniProtKB:Q62921}.
CC   -!- PTM: Phosphorylated. In vitro, phosphorylation inhibits auto-
CC       ubiquitination activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q62921}.
CC   -!- DISRUPTION PHENOTYPE: Impaired TNF-alpha-mediated NF-kappa-B activation
CC       and enhanced JNK-mediated apoptosis. {ECO:0000269|PubMed:19136968}.
CC   -!- SIMILARITY: Belongs to the RBR family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD24572.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH34555.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK088591; BAC40440.1; -; mRNA.
DR   EMBL; AK166075; BAE38556.1; -; mRNA.
DR   EMBL; AL831735; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL928568; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034555; AAH34555.1; ALT_INIT; mRNA.
DR   EMBL; AF124663; AAD24572.1; ALT_INIT; mRNA.
DR   CCDS; CCDS38273.1; -.
DR   RefSeq; NP_001077390.1; NM_001083921.1.
DR   RefSeq; NP_062679.2; NM_019705.3.
DR   PDB; 3B08; X-ray; 1.70 A; B/E/H/K=192-250.
DR   PDB; 3B0A; X-ray; 1.90 A; B/E=192-250.
DR   PDB; 5Y3T; X-ray; 2.40 A; A=1-140.
DR   PDBsum; 3B08; -.
DR   PDBsum; 3B0A; -.
DR   PDBsum; 5Y3T; -.
DR   SMR; Q9WUB0; -.
DR   BioGRID; 204899; 15.
DR   DIP; DIP-59198N; -.
DR   IntAct; Q9WUB0; 4.
DR   MINT; Q9WUB0; -.
DR   STRING; 10090.ENSMUSP00000105473; -.
DR   iPTMnet; Q9WUB0; -.
DR   PhosphoSitePlus; Q9WUB0; -.
DR   EPD; Q9WUB0; -.
DR   MaxQB; Q9WUB0; -.
DR   PaxDb; Q9WUB0; -.
DR   PeptideAtlas; Q9WUB0; -.
DR   PRIDE; Q9WUB0; -.
DR   ProteomicsDB; 267013; -.
DR   Antibodypedia; 6164; 291 antibodies.
DR   Ensembl; ENSMUST00000028964; ENSMUSP00000028964; ENSMUSG00000027466.
DR   Ensembl; ENSMUST00000109847; ENSMUSP00000105473; ENSMUSG00000027466.
DR   GeneID; 24105; -.
DR   KEGG; mmu:24105; -.
DR   UCSC; uc008nfd.1; mouse.
DR   CTD; 10616; -.
DR   MGI; MGI:1344372; Rbck1.
DR   eggNOG; KOG1815; Eukaryota.
DR   GeneTree; ENSGT00940000161130; -.
DR   HOGENOM; CLU_014998_1_0_1; -.
DR   InParanoid; Q9WUB0; -.
DR   OMA; MNCKDYQ; -.
DR   OrthoDB; 1086223at2759; -.
DR   PhylomeDB; Q9WUB0; -.
DR   TreeFam; TF323486; -.
DR   Reactome; R-MMU-5357905; Regulation of TNFR1 signaling.
DR   Reactome; R-MMU-5357956; TNFR1-induced NFkappaB signaling pathway.
DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   BioGRID-ORCS; 24105; 27 hits in 54 CRISPR screens.
DR   ChiTaRS; Rbck1; mouse.
DR   PRO; PR:Q9WUB0; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; Q9WUB0; protein.
DR   Bgee; ENSMUSG00000027466; Expressed in muscle tissue and 319 other tissues.
DR   ExpressionAtlas; Q9WUB0; baseline and differential.
DR   Genevisible; Q9WUB0; MM.
DR   GO; GO:0071797; C:LUBAC complex; ISS:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0003690; F:double-stranded DNA binding; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005080; F:protein kinase C binding; ISO:MGI.
DR   GO; GO:0140311; F:protein sequestering activity; ISO:MGI.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:MGI.
DR   GO; GO:0043130; F:ubiquitin binding; ISS:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISO:MGI.
DR   GO; GO:0051220; P:cytoplasmic sequestering of protein; ISO:MGI.
DR   GO; GO:0060546; P:negative regulation of necroptotic process; IGI:MGI.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISO:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:MGI.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISO:MGI.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISO:MGI.
DR   GO; GO:0097039; P:protein linear polyubiquitination; ISS:UniProtKB.
DR   GO; GO:0000209; P:protein polyubiquitination; ISO:MGI.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:MGI.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR026261; RBCK1/SHARPIN.
DR   InterPro; IPR044066; TRIAD_supradom.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR027370; Znf-RING_LisH.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR22770:SF35; PTHR22770:SF35; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00547; ZnF_RBZ; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF90209; SSF90209; 1.
DR   PROSITE; PS51873; TRIAD; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 1.
DR   PROSITE; PS50199; ZF_RANBP2_2; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Coiled coil; Metal-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..508
FT                   /note="RanBP-type and C3HC4-type zinc finger-containing
FT                   protein 1"
FT                   /id="PRO_0000056296"
FT   DOMAIN          55..119
FT                   /note="Ubiquitin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   ZN_FING         188..220
FT                   /note="RanBP2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   ZN_FING         280..330
FT                   /note="RING-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   ZN_FING         349..409
FT                   /note="IBR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   ZN_FING         445..474
FT                   /note="RING-type 2; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   REGION          1..268
FT                   /note="Interaction with TAB2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYM8"
FT   REGION          1..218
FT                   /note="Interaction with IRF3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYM8"
FT   REGION          69..131
FT                   /note="Interaction with RNF31"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYM8"
FT   REGION          276..504
FT                   /note="TRIAD supradomain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   COILED          231..259
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        458
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           280
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           283
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           298
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           300
FT                   /note="Zinc 2; via pros nitrogen"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           303
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           306
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           321
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           330
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           369
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           374
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           389
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           392
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           397
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           400
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           404
FT                   /note="Zinc 4; via tele nitrogen"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           409
FT                   /note="Zinc 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           445
FT                   /note="Zinc 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           448
FT                   /note="Zinc 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           463
FT                   /note="Zinc 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   METAL           466
FT                   /note="Zinc 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01221"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYM8"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BYM8"
FT   MOD_RES         328
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:17947660"
FT   CONFLICT        322
FT                   /note="P -> S (in Ref. 1; BAE38556)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        406
FT                   /note="H -> R (in Ref. 1; BAC40440)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..20
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   HELIX           24..36
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   STRAND          41..45
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   STRAND          55..63
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   STRAND          68..75
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   HELIX           81..92
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   HELIX           96..98
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   STRAND          99..107
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   STRAND          112..114
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   HELIX           115..117
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   STRAND          125..130
FT                   /evidence="ECO:0007744|PDB:5Y3T"
FT   STRAND          194..196
FT                   /evidence="ECO:0007744|PDB:3B08"
FT   TURN            198..200
FT                   /evidence="ECO:0007744|PDB:3B08"
FT   TURN            212..214
FT                   /evidence="ECO:0007744|PDB:3B08"
FT   HELIX           232..245
FT                   /evidence="ECO:0007744|PDB:3B08"
SQ   SEQUENCE   508 AA;  57534 MW;  CBD3B40CD4E55180 CRC64;
     MDEKTKKAEE MALSLARAVA GGDEQAAIKY ATWLAEQRVP LRVQVKPEVS PTQDIRLCVS
     VEDAYMHTVT IWLTVRPDMT VASLKDMVFL DYGFPPSLQQ WVVGQRLARD QETLHSHGIR
     RNGDGAYLYL LSARNTSLNP QELQRQRQLR MLEDLGFKDL TLQSRGPLEP VLPKPRTNQE
     PGQPDAAPES PPVGWQCPGC TFINKPTRPG CEMCCRARPE TYQIPASYQP DEEERARLAG
     EEEALRQYQQ RKQQQQEGNY LQHVQLEQRS LVLNTEPTEC PVCYSVLAPG EAVVLRECLH
     TFCRECLQGT IRNSQEAEVA CPFIDSTYSC PGKLLEREIR ALLSPEDYQR FLDLGVSIAE
     NRSTLSYHCK TPDCRGWCFF EDDVNEFTCP VCTRVNCLLC KAIHEHMNCR EYQDDLALRA
     QNDVAARQTT EMLKVMLQQG EAMHCPQCRI VVQKKDGCDW IRCTVCHTEI CWVTKGPRWG
     PGGPGDTSGG CRCRVNGIPC HPSCQNCH
//
